Food banks nationwide are being pinched by record demand, high food prices, and hundreds of millions of dollars in federal budget cuts.

We want you to take advantage of everything Clinical Advisor has to offer. To view unlimited content, log in or register for free.

The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

No association seen for incontinence with MVPA classification, but link seen with type 2 diabetes, dyslipidemia, and stroke.

HealthDay News — The US Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) announced a new initiative called “Generation Gold Standard” to develop ...

"I have tremendous confidence in the many scientists, inspectors, and staff at the FDA to help accomplish these goals and am excited to work with them," said new FDA commissioner Dr Marty Makary.

There is a difference between the terms "tardive dyskinesia" and "tardive syndrome" that clinicians should be aware of when providing care.

Three children have died in the most recent outbreak of measles, to date. This article reviews the signs, symptoms, and ...

An endocrinologist and nutritionist discuss the science behind the circulating health trend of "hormone diets." ...

Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.

Researchers evaluated the effectiveness of both behavioral and pharmacologic interventions for improving sleep quality in fibromyalgia.

Tepylute is indicated for the treatment of adenocarcinoma of the breast or ovary . It is now supplied as a multiple-dose vial containing 100mg of thiotepa, in addition to the previously approved ...